Amiodarone increases bleeding compared with flecainide or sotalol in patients on anticoagulant therapy
A retrospective analysis of Medicare patients who started an anticoagulant and then amiodarone found that they had a 44% increased risk for bleeding-related hospitalization compared to those on other antiarrhythmics and that this risk was higher with rivaroxaban than apixaban.
The World Health Organization (WHO) cited a lack of evidence suggesting that short-term use of nonsugar sweeteners affected body weight or other measures of adiposity, as well as possible long-term undesirable effects on noncommunicable diseases and death.
A 36-year-old woman is evaluated during a routine wellness visit. She is asymptomatic and has no medical problems. Her mother has rheumatoid arthritis, and the patient is concerned that she might also develop the disease. Following a physical exam, what is most likely to reduce this patient's risk for developing rheumatoid arthritis?
In a study that compared survivors with their siblings, the 35-year mean cumulative count of major surgical interventions at least five years after diagnosis was 206.7 per 100 versus 128.9 per 100, respectively.
A case study developed by ACP's Ethics, Professionalism, and Human Rights Committee and the Center for Ethics and Professionalism addresses the ethical issues associated with “slow” or “show” codes.
A full recording of “COVID-19 Is No Longer a Public Health Emergency: Implications for Patients and Clinicians” is available online.